Real-time enrollment status for this secondary aml clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:07 PM UTC
| NCT Number | NCT07250646 |
| Recruiting Status | Recruiting |
| Condition | Secondary AML |
| Phase | PHASE1 |
| Target Enrollment | 28 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Aspera Biomedicines, Inc. |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 16, 2026: Clinical trial NCT07250646 is currently recruiting participants. This phase1 study for secondary aml is actively seeking new participants at 2 locations across the United States. The study is sponsored by Aspera Biomedicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07250646 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07250646 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.